Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Wroclaw
Clinical trial register · Poland

Clinical Trials in Wroclaw, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Poland and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2705 matching records held by the registry are in this view. Synced 28 Oct 2026, 03:18 UTC
2705
Studies in scope
all four open statuses
1389
Recruiting now
open to new participants
512
Lead sponsors
across recruiting studies
Top sites
Krakow 38 Warsaw 36 Lodz 24 Wroclaw 22 Bialystok 20
Narrow the registerReset
Recruitment status
Phase
Site location
Krakow38 Warsaw36 Lodz24 Wroclaw22 Bialystok20
All 60 locations
Target enrolment
to

Trials with a site in Wroclaw

22 of 2705 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Poland
Start
Recruiting
Eli Lilly and Company
Phase 3
150
Lodz, Rzeszów, Stanisławów Pierwszy, Warsaw, Warszewo, Wroclaw
2026-09-25
Recruiting
Eli Lilly and Company
Phase 2
60
Gdansk, Krakow, Ostrowiec Świętokrzyski, Wroclaw
2026-04-14
Recruiting
A Study of LY4005130 in Adult Participants With Non-Segmental Vitiligo
NCT07533019Vitiligo, Non-Segmental Vitiligo (NSV)
Eli Lilly and Company
Phase 2
66
Gdansk, Krakow, Ostrowiec Świętokrzyski, Wroclaw
2026-04-14
Recruiting
Eli Lilly and Company
Phase 3
1,000
Bialystok, Bielsko-Biala, Gdansk, Krakow, Leszno, Poznan, Szczecin, Wroclaw
2026-02-09
Recruiting
Eli Lilly and Company
Phase 3
1,980
Bialystok, Krakow, Lodz, Lublin, Poznan, Wroclaw, Zabrze
2026-02-06
Recruiting
Eli Lilly and Company
Phase 3
300
Gdansk, Lodz, Warsaw, Wroclaw
2026-02-05
Recruiting
Eli Lilly and Company
Phase 3
1,205
Bydgoszcz, Elblag, Grudziądz, Komorniki, Leszno, Puławy, Wroclaw
2025-10-31
Recruiting
Eli Lilly and Company
Phase 3
1,000
Bydgoszcz, Skórzewo, Szczecin, Warsaw, Wroclaw
2025-09-30
Recruiting
Eli Lilly and Company
Phase 1/2
68
Katowice, Krakow, Skorzewo, Torun, Wroclaw
2025-07-30
Recruiting
Eli Lilly and Company
Phase 3
350
Katowice, Opole, Piotrkow Trybunalski, Poznan, Rzeszów, Szczecin, Warsaw, Wroclaw
2025-06-26
Recruiting
Eli Lilly and Company
Phase 3
290
Lublin, Opole, Piotrkow Trybunalski, Poznan, Rzeszów, Szczecin, Warsaw, Wroclaw
2025-06-26
Active, closed
Eli Lilly and Company
Phase 3
487
Bialystok, Bydgoszcz, Piotrkow Trybunalski, Przemyśl, Tarnów, Warsaw, Wroclaw
2025-04-30
Active, closed
Eli Lilly and Company
Phase 3
487
Bialystok, Bydgoszcz, Piotrkow Trybunalski, Przemyśl, Tarnów, Warsaw, Wroclaw
2025-04-30
Active, closed
Eli Lilly and Company
Phase 3
974
Bialystok, Bydgoszcz, Piotrkow Trybunalski, Przemyśl, Tarnów, Warsaw, Wroclaw
2025-04-30
Recruiting
Eli Lilly and Company
Phase 2
200
Bialystok, Gdansk, Krakow, Lodz, Lublin, Tarnów, Warsaw, Wroclaw
2025-03-28
Recruiting
Eli Lilly and Company
Phase 3
150
Krakow, Warsaw, Warszewo, Wroclaw
2024-11-18
Recruiting
Eli Lilly and Company
Phase 3
125
Krakow, Lodz, Rzeszów, Stanisławów Pierwszy, Warsaw, Wroclaw
2024-11-18
Recruiting
Eli Lilly and Company
Phase 3
510
Bialystok, Katowice, Kielce, Krakow, Poznan, Warsaw, Wieliczka, Wroclaw
2024-04-29
Recruiting
A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
NCT04844606Ulcerative Colitis, Ulcerative Colitis Chronic, Inflammatory Bowel Diseases, Crohn's Disease
Eli Lilly and Company
Phase 3
150
Rzeszów, Szczecin, Warsaw, Wroclaw
2021-05-26
Active, closed
Eli Lilly and Company
Phase 3
996
Poznan, Bydgoszcz, Krakow, Wadowice, Swidnica, Wroclaw, Lublin, Zamość
2020-06-22
Active, closed
Eli Lilly and Company
Phase 3
1,736
Poznan, Bydgoszcz, Krakow, Ścinawa, Wroclaw, Lublin, Warsaw, Warsawawa
2020-06-19
Active, closed
Eli Lilly and Company
Phase 3
5,637
Konin, Poznan, Wroclaw, Lublin, Warsaw, Opole, Gdansk, Gdynia
2017-07-12
Rows per page Showing 1–22 of 22
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Polish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 29 October 2026. https://priyalifescience.com/clinical-trials-poland/city/wroclaw

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Poland and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,705 studies in total at the last sync on 28 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 22 of those studies with a site in Wroclaw that also match the filters currently applied.

How many clinical trials are recruiting in Wroclaw?

16 of the 22 studies on this page are recruiting new participants as of the 28 Oct 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 6 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Wroclaw), 22 studies
PhaseStudiesRecruitingShare
Phase 3181281.8%
Phase 23313.6%
Phase 1/2114.5%

Most active sponsors

Lead sponsors with the most studies (Wroclaw)
Lead sponsorStudiesRecruiting
Eli Lilly and Company2216
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.